In addition to the FDA application for approval, Merck will also advanced with regulatory filings in countries outside the United States.The Advisory Committee ‘s recommendation was used to test the efficacy and safety results from studies of raltegravir in combination with optimized background therapy in treatment-experienced HIV – infected patients receiving antiretroviral therapy had failed, and the HIV-resistant had at least one drug in each of the three classes of oral skills.
Prevalence of HIV / AIDSIn 2003, more than one million Americans are living with HIV, and it is estimated that approximately 40,000 new cases of HIV / AIDS are diagnosed each in the U.S. In the U.S. I Worldwide an estimated 40 million people living with HIV / AIDS are infected, and more than four million new infections occurred in 2006.ii AIDS a leading cause of infectious disease mortality worldwide accounts for nearly three million deaths last year alone.iii.Worldwide renowned may soon easy a little easier for parents of autistic children.
Katherine Morley, from the Institute of Molecular Life Sciences, efforts year time now the final year three-year Ian Scott Fellowship , where she examines of genetic factors which will influence the ability of people stop genes genes like the effects of changes medicines used in order help people give up smoking. In all , have pick up research by UQ scholarship amounting to exceeding $ 128,000 from the Australian Rotary Healthcare Research Fund.